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AIMS: Preservation of renal function in children with congenital neurogenic bladder is an important goal of
treatment for the disease. This study analyzed the evolution of renal function in patients with congenital
neurogenic bladder.
METHODS: We reviewed the records of 58 pediatric patients with respect to the following attributes: gender, age,
etiology of neurogenic bladder, reason for referral, medical/surgical management, episodes of treated urinary tract
infections, urodynamics, DMSA scintigraphy, weight, height, blood pressure, glomerular filtration rate,
microalbuminuria and metabolic acidosis. Statistical analysis was performed, adopting the 5% significance level.
RESULTS: The mean age at presentation was 4.2 ¡ 3.5 years. Myelomeningocele was the most frequent etiology
(71.4%). Recurrent urinary tract infection was the reason for referral in 82.8% of the patients. Recurrent urinary
tract infections were diagnosed in 84.5% of the patients initially; 83.7% of those patients experienced improvement
during follow-up. The initial mean glomerular filtration rate was 146.7 ¡ 70.1 mL/1.73 m
2/min, and the final mean
was 193.6 ¡ 93.6 mL/1.73 m
2/min, p = 0.0004. Microalbuminuria was diagnosed in 54.1% of the patients initially
and in 69% in the final evaluation. Metabolic acidosis was present in 19% of the patients initially and in 32.8% in
the final assessment.
CONCLUSIONS: Patient referral to a pediatric nephrologist was late. A reduction in the number of urinary tract
infections was observed with adequate treatment, but microalbuminuria and metabolic acidosis occurred
frequently despite adequate management.
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INTRODUCTION
Neurogenic bladder is considered an important risk factor
for chronic renal failure.
1 It is well established that the best
way of preserving renal function is to allow the bladder to
fill and be emptied regularly.
2 Clean intermittent catheter-
ization has a critical role in the prevention of urinary tract
infections (UTIs) and in reducing bladder pressure.
3,4
Anticholinergic agents help reducing bladder pressure and
improve bladder capacity.
5
The quantification of glomerular filtration rate (GFR) and
the presence of microalbuminuria and metabolic acidosis
are frequently utilized for the assessment of the glomerular
and tubular functions in chronic kidney disease. The GFR,
calculated from serum creatinine, and the evaluation of
microalbuminuria, provide information on glomerular
function. Microalbuminuria has emerged as a risk marker
for chronic renal disease and its use in the diagnosis of
incipient chronic renal lesion of several causes has been
stimulated.
6 Metabolic acidosis is a marker of tubular lesion
and is commonly associated with renal function loss and
also with obstructive uropathies.
7
The aim of this study was to evaluate the evolution of
glomerular and tubular renal function in patients with
congenital neurogenic bladder treated by pediatric nephrol-
ogists, identifying factors related to worsening of renal
function in order to suggest treatment modifications.
PATIENTS AND METHODS
We have retrospectively reviewed the clinical records of
58 children with congenital neurogenic bladder treated at
‘‘Voiding Dysfunction Clinic’’, of ‘‘Instituto da Crianc ¸a do
Hospital das Clinicas da Faculdade de Medicina da
Universidade de Sa ˜o Paulo’’ (Sa ˜o Paulo, Brazil), during
the years 1998 – 2006. This study was approved by the
institution ethics board.
Data were collected on: gender, age at presentation to our
unit, follow-up period in our service, etiology of neurogenic
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189bladder, reason of referral, previous and follow-up medi-
cal/surgical management, previous and follow-up epi-
sodes of treated UTIs, initial urodynamic evaluation and
DMSA scintigraphy, initial and follow-up weight, height
and blood pressure, initial and follow-up levels of serum
creatinine, microalbuminuria, venous pH and serum bicar-
bonate.
As this is a retrospective study, we have defined treated
UTI as every urinary tract infection episode registered as
such in the patient’s records, either in the admission history
or in the outpatient clinic follow-up, and for which antibiotic
therapy was prescribed by the attending physician.
Z-scores were calculated for weight and height and
values between -2 and +2 standard deviations were con-
sidered normal.
8,9 GFR was established from serum creat-
inine, based on Schwartz’s formula.
10 Microalbuminuria
analysis was performed based on a single urine sample and
was defined as values higher than 30 mg/g of creatinine.
11
Metabolic acidosis was defined as bicarbonate levels lower
than 20 mEq/L, in a minimum of 2 consecutive venous
blood samples, or when on alkali therapy.
A complementary analysis was performed regarding
microalbuminuria:
– Group without microalbuminuria: patients in whom
microalbuminuria was absent in the initial and final
evaluations, or children in whom microalbuminuria was
present in the initial assessment but disappeared during
the follow-up study period.
– Group with microalbuminuria: patients in whom micro-
albuminuria was present in the final assessment.
The occurrence of metabolic acidosis was evaluated in
initially non –acidotic patients by Kaplan Meier curves. This
analysis was done to identify factors possibly related to the
start of metabolic acidosis. Data were compared according
to gender (male/female), period of follow-up (less than 6
years/ equal to or more than 6 years), age at presentation to
our service (less than 3 years of age/ equal to or more than 3
years of age), presence of renal parenchymal damage on
initial DMSA scintigraphy (yes/no) and history of UTI
(yes/no).
Another complementary analysis was performed for
metabolic acidosis considering two groups of patients:
– Group without metabolic acidosis: patients in whom
acidosis was absent in the initial and final evaluations or
in whom acidosis was present initially but disappeared
during follow-up.
– Group with metabolic acidosis: patients in whom
acidosis existed in the first and final evaluations or in
whom acidosis has developed during the follow-up
study period and was present in the final assessment.
The obtained results were described as means, standard
deviations, medians, minimum and maximum values, or as
frequencies and percentages.
STATISTICS
Comparison between initial and final evaluations for
continuous quantitative variables was done using the
Student’s t-test for paired samples. The association between
dichotomous variables was performed considering the
Fisher’s exact test. For evaluation of patient’s outcomes and
comparison of subgroups defined by dichotomous variables,
Kaplan-Meier curves were performed and Log-rank test was
applied. P values , 0.05 indicated statistical significance.
RESULTS
Of the 58 children studied, 33 were females (56.9%). The
mean age at presentation to our unit was 4.2 ¡ 3.5 (0-12.8)
years. The mean of follow-up period was 3.8 ¡ 3.1 (0.5 –
13.5) years. The mean age at the final evaluation was 8.0 ¡
5.3 (0.7 – 19.2) years. The most frequent aetiology of
neurogenic bladder was myelomeningocele (MMC) in 42
(71.4%), followed by sacral agenesis in 7 (12.1%), spina
bifida occulta in 6 (10.4%), teratoma in 2 (3.4%) and flaccid
tetraparesis in 1 patient (1.7%). The main reason that led to
referral to our service was recurrent UTI in 48 (82.8%)
patients, enuresis in 5 (8.6%) patients and urinary retention
in 5(8.6%) patients.
None of the 58 children had been evaluated by nephrol-
ogists before referral to our service. Most of them were
under the care of paediatricians or urologists. Therapeutic
interventions for neurogenic bladder, performed before
children arrived in our service and during follow-up are
shown in Table 1.
Of the 49 patients with history of UTI, 41 showed
improvement (83.7%). Lack of improvement or increase in
UTI episodes occurred in 12 (20.7%) patients (table 2).
Of the 58 children, 41 (70.7%) had their first urodynamic
evaluation performed after the arrival at our unit. In these
children, bladder capacity was reduced in 23 (56.1%) and
Table 1 - Therapeutic interventions for neurogenic
bladder performed before and after arrival at pediatric
nephrology service.
BEFORE AFTER
None 14 (24.1%) 0
AP
1 22 (37.9%) 8 (13.8%)
AP+ IC
2 4 (6.9%) 5 (8.6%)
AP+ IC+ anticholinergic agents 5 (8.6%) 19 (32.7%)
AP+ anticholinergic agents 0 2 (3.6%)
Vesicostomy 7 (12.0%) 10
* (17.2%)
Bladder augmentation + IC 4 (6.9%) 14
* (24.1%)
Correction of vesicoureteral reflux 2 (3.6%) 0
TOTAL 58 58
1Antibacterial prophylaxis
2Intermittent catheterization
*During the follow-up period at our service, 4 children underwent
vesicostomy and 10 underwent bladder augmentation (1 of whom with
closure of vesicostomy). In this way, in the final evaluation bladder
augmentation was present in 14 children and vesicostomy in 10.
Table 2 - Initial and final evaluations regarding urinary
tract infections (UTI), N= 58.
Initial evaluation Final evaluation
9 without history of
UTI (15.5%)
5 remained free from UTI (8.6%)
4 had at least 1 episode of UTI (6.9%)
49 with history of
UTI (84.5%)
25 became free from UTI (43.1%)
16 had a reduction of at least 50% in
episodes of UTI (27.6%)
8 maintained or had an increase in UTI
episodes (13.8%)
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190detrusor-sphincter dyssynergia was found in 6 (14.6%).
Mean detrusor leaking pressure was 46.1 cm H2O.
Of the 58 children, 45 (77.6%) had their DMSA scinti-
graphy performed after the arrival at our unit and 24
(53.3%) of these patients had renal scars.
Mean initial and final z-score for weight were – 1.5 ¡ 2.1
(- 6.96 to + 2.78) and – 1.5 ¡ 2.2 (- 6.91 to +2.53) respectively.
Mean z-score for initial and final height were – 1.8 ¡ 1.8
(-5.27 to + 1.37) and – 2.1 ¡ 1.8 (-6.19 to + 1.08) respectively.
Blood pressure was normal in 39 (68.4%) patients in the
initial evaluation and in 38 (65.5%) in the final assessment.
Pre-hypertension was diagnosed in 7 (12.3%) patients
initially and in 2 (3.5%) in the final assessment.
Hypertension was diagnosed in 12 (20.2%) children in the
initial evaluation and in 18 (31%) in the final assessment. In
the period before referral to our service only three of the 11
children with hypertension were taking medication. All of
the children who were diagnosed as hypertensive in our
service were started on antihypertensive agents. When there
was coexistence with microalbuminuria, angiotensin con-
verting inhibitors (ACE inhibitors) or angiotensin II recep-
tor-1 blockers were preferred.
Mean initial and final GFR were 146.7 ¡ 70.1 mL/
1.73 m
2/min (50.2 to 445.5) and 193.6 ¡ 93.6 mL/1.73 m
2/
min (90.2 to 605) respectively. A significant difference
between mean initial GFR and mean final GFR was found
(p=0.0004) (figure 1).
Microalbuminuria analysis was possible in 37 patients
(63.8%) initially and in 42 children (72.4%) in the final
assessment. Microalbuminuria was found in 20 (54.1%)
patients at presentation and in 29 children (69.0%) in the
final assessment. None of patients with microalbuminuria at
the time of presentation was taking medication on that
account. Treatment with ACE inhibitors or angiotensin II
receptor-1 blockers was initiated after identification of
microalbuminuria in all of the patients.
The comparison between the group without microalbu-
minuria and the group with microalbuminuria is on the
table 3, 4 and 5. There was no difference regarding gender,
aetiology of neurogenic bladder, history of UTI, blood
pressure, metabolic acidosis and number of urinary tract
infections during follow up. There was also no significant
difference with regard to age at presentation, age in the final
assessment, period of follow-up, initial/final weight z-score,
difference of weight z-score, initial/final height z-score,
difference of height z-score, initial/final GFR, and differ-
ence of GFR.
Venous pH and serum bicarbonate levels were assessed
in all patients. Metabolic acidosis was found in 11 (19%)
patients initially and in 19 children (32.8%) in the final
evaluation. Only 3 of the 11 patients with acidosis in the
initial evaluation were on alkali therapy on referral to our
service. All of the patients in whom acidosis was diagnosed
in our service were started on sodium bicarbonate to
maintain bicarbonate serum level $ 24 mEq/L.
The 47 patients who did not present metabolic acidosis in
the initial evaluation were analyzed by Kaplan-Meier curves
for duration of disease (coincident with patient’s age).
A significant difference was confirmed with regard to age
at presentation (children with less than 3 years of age versus
children aged 3 or more). Initiation of metabolic acidosis
during the follow-up period was more frequent in the
Figure 1 - Mean initial and final glomerular filtration rate in 58 children with congenital neurogenic bladder.
Table 3 - Comparison between the group without
microalbuminuria and the group with microalbuminu ´ria
regarding gender, etiology of neurogenic bladder and
history of UTI.
Classification
Group with
microalbuminu ´ria
Group without
microalbuminu ´ria P value*
Gender n=29 n=17 0.545
Male 12 (41.4%) 9 (52.9%)
Female 17 (58.6%) 8 (47.1%)
Aetiology n=29 n=17 1**
Myelomeningocele 20 (69.0%) 11 (64.7%)
Sacral agenesis 4 (13.8%) 2 (11.8%)
Teratoma 1 (3.4%) 1 (5.9%)
Spina bifida occulta 4 (13.8%) 2 (11.8%)
Flaccid tetraparesis - 1 (5.9%)
History of UTI n=29 n=17 0.083
Yes 27 (93.1%) 12 (70.6%)
No 2 (6.9%) 5 (29.4%)
(*) Fisher’s exact test
(**) Myelomeningocele x ? myelomeningocele
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191children who presented earlier to our service (figure 2). The
development of metabolic acidosis did not present an
association with male/female gender, duration of follow-
up (, 6 years/ .= 6 years), presence/absence of history of
UTI, presence/ absence of microalbuminuria in the initial
evaluation, presence/absence of parenchymal damage on
DMSA scintigraphy.
The comparison between the group without acidosis and
the group with acidosis showed statistically significant
lower values of final weight z-score (p=0.048), initial height
z-score (p=0.047) and final height z-score (p=0.022) in the
group without acidosis. There was no significant difference
between these two groups regarding other studied vari-
ables: gender, aetiology of neurogenic bladder, history of
UTI, blood pressure, metabolic acidosis, number of UTI
episodes, age at presentation, age in final assessment,
duration of follow-up, initial weight z-score, difference of
weight z-score, difference of height/stature z-score, initial/
final GFR, and difference of GFR (tables 6, 7 and 8).
DISCUSSION
A comprehensive renal function follow-up, preferably by
a pediatric nephrologist, should be routinely performed in
children with congenital neurogenic bladder starting early
in the course of the disease, as they are at risk of developing
permanentrenaldamage.Unfortunately,inthepresent study,
the first renal evaluation occurred at a mean of 4.2 years of
age. At the time of presentation, 7 patients had metabolic
acidosis without therapy, 7 patients were hypertensive
without antihypertensive treatment and 20 patients demon-
strated microalbuminuria without antiproteinuric therapy.
Ulsenheimer et al retrospectively analyzed 36 children with
myelomeningocele in a Brazilian University Hospital and
showed that only 45% had been submitted to an urinary tract
evaluation.
12 Kari reported on 11 children with neurogenic
bladder in Saudi Arabia whose mean age at follow-up
initiation was 6.6 years, all of them had a GFR lower than
50mL/1.73m
2/min
1.Di ketal
4presenteddataon176patients
with spina bifida who had been referred to an University
Hospitalinthenewbornperiodandshowedthatanearlystart
to therapy has helped to safeguard renal function.
MMC is the leading cause of congenital neurogenic
bladder in world. Sacral agenesis is less common and is
almost always associated with maternal insulin-dependent
diabetes mellitus. We found that 71.4% children had MMC
and 12.1% had sacral agenesis, in agreement with data from
Cass et al, who found 78.2% MMC and 4.4% sacral agenesis
in 413 patients with neurogenic bladder.
3
In our data, referral of 84.5% of children was motivated by
UTI. Ghoniem et al showed data on 61 patients with MMC
Table 4 - Comparison between the group without
microalbuminuria and the group with microalbuminu ´ria
regarding blood pressure, metabolic acidosis and number
of urinary tract infections during follow up.
Classification
Group with
microalbuminu ´ria
Group without
microalbuminu ´ria p value*
Blood pressure n=29 n=17 0.635
Equal or better 25 (86.3%) 16 (94.1%)
Worse 4 (13.7%) 1 (5.9%)
Acidosis n=29 n=17 0.998
Equal or better 24 (82.8%) 14 (82.3%)
Worse 5 (17.2%) 3 (17.7%)
ITU n=29 n=17 0.1725
Better 20 (69.0%) 15 (88.2%)
Equal or worse 9 (31.0%) 2 (11.8%)
(*) Fisher’s exact test
Table 5 - Comparison between the group without microalbuminuria and the group with microalbuminu ´ria regarding to
age at presentation, age in the final assessment, period of follow-up, initial/final weight z-score, difference of weight z-
score, initial/final height z-score, difference of height z-score, initial/final GFR, and difference of GFR.
variable Micro-albuminu ´ria n medium minimum maximum Valor de p*
Age at presentation no 17 4.4 0.2 12.8 0.859
yes 29 4.6 0 12.6
Age in the final assessment no 17 8.5 2.2 19.2 0.873
yes 29 8.8 2.5 19.0
Period of follow-up no 17 4.1 0.8 8.0 0.951
yes 29 4.2 0.5 13.5
Initial weight z-score no 17 -1.6 -5.2 1.0 0.355
yes 29 -1.0 -6.9 2.8
Final weight z-scorel no 17 -1.2 -5.9 1.7 0.990
yes 29 -1.2 -7.0 2.5
Difference of weight z-score no 17 0.4 -1.8 2.9 0.071
yes 29 -0.2 -3.1 0.9
Initial height z-score no 17 -1.8 -5.2 0.7 0.769
yes 29 -1.6 -5.3 1.4
Final height z-score no 17 -1.9 -5.5 0.3 0.717
yes 29 -2.0 -6.0 1.1
Difference of height z-score no 17 -0.1 -1.4 2.2 0.248
yes 29 -0.5 -2.6 1.6
Initial GFR no 17 157.0 77 269.5 0.376
yes 29 139.1 56.4 445.5
Final GFR no 17 195.5 127.9 330.0 0.760
yes 29 205.0 90.2 605.0
Difference of GFR no 17 38.5 -66.4 171.4 0.349
yes 29 65.9 -48.1 487.7
(*) Student’s t-test for paired samples.
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192in whom history of UTI was present in 70.5%.
2 We have
observed a reduction of the number of UTI episodes after
initiation of bladder catheterization, in agreement with the
experience of Cass et al.
5
In the present study, the mean z-scores for initial and final
weight and for initial height were within the normal range,
but the mean final height z score was below the expected
levels, on account of five children with very low weight and
height z-scores, which had a negative impact in the overall
final weight and height mean z-scores. Our data is in
agreement with Hayes-Allen
13 who has studied children
with MMC and observed that 88% were below the 10
th
percentile for height, and with Rosenblum et al, who have
studied 99 children with MMC and found that 50.5% were
below the 3
rd percentile for height.
14
An increase in GFR was demonstrated during the
patients’ follow-up. Some children had very high rates of
GFR, such as 600 mL/1.73 m
2/min. and none presented a
final GFR below 90 mL/1.73 m
2/min. In the present study,
no association was evident between GFR and microalbumi-
nuria or metabolic acidosis, or between, microalbuminuria
and maintenance or increase of the number of UTI episodes,
in spite of the potential production of renal scarring, loss of
renal parenchyma and secondary glomerulosclerosis which
is related to repetitive episodes of UTI. There was also no
association between microalbuminuria and systemic hyper-
tension, although hypertension can be a cause or a
consequence of renal injury with evolution to hyperfiltration
Figure 2 - Kaplan-Meier curves for the age at presentation to Nephrology Clinic and start of metabolic acidosis (comparing children
aged less than 3 years to children with more than 3 years of age).
Table 6 - Comparison between the group without
metabolic acidosis and the group with metabolic acidosis
regarding gender, aetiology of neurogenic bladder and
history of UTI.
Classification
Group with
metabolic
acidosis
Group without
metabolic
acidosis p value*
Gender n=19 n=39 0.399
Male 10 (52.6%) 15 (38.5%)
Female 9 (47.4%) 24 (61.5%)
Aetiology n=19 n=39 0.119**
Myelomeningocele 11 (57.9%) 31 (79.5%)
Sacral agenesis 2 (10.5%) 5 (12.8%)
Teratoma 1 (5.3%) 1 (2.6%)
Spina bifida occulta 4 (21.0%) 2 (5.1%)
Flaccid tetraparesis 1 (5.3%) -
History of UTI n=19 n=39 1
Yes 17 (89.5%) 33 (84.6%)
No 2 (10.5%) 6 (15.4%)
(*) Fisher’s exact test
(**) Myelomeningocele x ? myelomeningocele
Table 7 - Comparison between the group without
metabolic acidosis and the group with metabolic acidosis
regarding blood pressure, microalbuminuria and number
of urinary tract infections during follow up.
Classification
GrOup WITH
METABOLIC
acidosIS
GrOup
WITHoUT
METABOLIC
acidosIS p value*
Blood pressure n=19 n=39 0.987
Equal or better 17 (89.5%) 35 (89.7%)
Worse 2 (10.5%) 4 (10.3%)
Microalbuminuria n=12 n=21 0.997
Equal or better 10 (83.3%) 18 (85.7%)
Worse 2 (16.7%) 3 (14.3%)
UTI n=19 n=39 0.999
Better 16 (84.2%) 29 (74.4%)
Equal or worse 3 (15.8%) 10 (25.6%)
(*) Fisher’s exact test.
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15 The absence of these associations
is probably related to the retrospective design of the study,
in which children in different stages of kidney function
compromise are compared as a group. It is unfortunate that
the only evaluation of glomerular filtration rate that was
available for this restrospective study is creatinine/creati-
nine clearance which may overestimate GFR in situations of
low body muscle mass
16 which is frequently the case of
children with neurogenic bladder. Sutherland in 1997
17 and
del Gado et al in 2003
17 demonstrated that children with
MMC had smaller kidneys than healthy children, so in spite
of the eventual bias of measuring GFR using creatinine as
marker, the marked incidence of microalbuminuria in the
described patients and its inherent association with hyper-
filtration, a possible component of renal hipoplasia, which
might explain the glomerular hyperfiltration verified in
most of our patients at initiation and during clinical follow
up, cannot be discarded
Patients with obstructive uropathies may develop meta-
bolic acidosis which can persist after decompression.
7 Two
of the presently described patients recovered from acidosis
after the relief of urinary obstruction. According to Mingin
et al
19 lower values of serum bicarbonate may be associated
with augmentation enterocystoplasty. Of the 19 patients
with acidosis, 4(21.1%) have manifested a post-augmenta-
tion reduction of serum bicarbonate levels.
It is interesting that the children who presented earlier to
our service (aged less than 3 years) developed metabolic
acidosis more often than the late referrals. A possible reason
for that finding is that, as a reference university service, our
unit cares for children with a more severe pattern of disease.
In fact, all the presently described patients were clearly
symptomatic at arrival, with history of urinary retention or
UTIs, unfortunately we have not received any patient for
purely preventive follow-up.
The presence of metabolic acidosis is usually associated
with low weight/height gain,
20 but in our study the
children who developed acidosis presented significantly
higher final weight z-score and initial and final height z-
scores than the children without acidosis. A possible
explanation for this finding is that we have used different
criteria for diagnosing and treating metabolic acidosis. We
have diagnosed metabolic acidosis with two consecutive
venous serum bicarbonate below 20 mEq/L but our
treatment goal for metabolic acidosis was a bicarbonate
serum level $ 24 mEq/L. This discrepancy probably
favoured the growth of the treated children. We have made
that option to alleviate the burden of the caretaker, for
whom the introduction of an unnecessary medication, four
times a day, may change compliance into burn-out. Our
findings suggest that for the benefit of the patients’ growth
and development, the bicarbonate level for diagnosis of
metabolic acidosis should be increased.
CONCLUSION
Children with congenital neurogenic bladder were
referred late for renal evaluation, with a mean age of 4.2
years. Renal damage was evident in at least 53.3% of the
patients on arrival to our service according to available
DMSA scans. Despite adequate management, a significant
number of patients developed microalbuminuria and meta-
bolic acidosis, with GFR above normal range suggesting
hyperfiltration. The data of this study strongly indicate that
these patients should have initiated treatment much earlier,
preferably immediately after birth. Close follow up of these
Table 8 - Comparison between the group without acidosis and the group with acidosis regarding to age at presentation,
age in the final assessment, period of follow-up, initial/final weight z-score, difference of weight z-score, initial/final
height z-score, difference of height z-score, initial/final GFR, and difference of GFR.
variable Acidosis n Mediam minimum maximum p value*
Age at presentation no 39 4.2 0 12.5 0.860
yes 19 4.4 0.4 12.8
Age in the final assessment no 39 7.8 0.7 18.3 0.560
yes 19 8.6 1.0 19.2
Period of follow-up no 39 3.6 0.3 13.5 0.427
yes 19 4.3 0.5 8.8
Initial weight z-score no 39 -1.8 -7.0 2.8 0.129
yes 19 -0.8 -3.4 2.7
Final weight z-scorel no 39 -1.9 -6.9 2.5 0.048
yes 19 -0.7 -3.6 1.9
Difference of weight z-score no 39 -0.1 -3.2 3.0 0.329
yes 19 0.2 -2.0 2.9
Initial height z-score no 39 -2.2 -5.3 0.7 0.047
yes 19 -1.2 -4.6 1.4
Final height z-score no 39 -2.5 -6.2 0.3 0.022
yes 19 -1.4 -4.9 1.1
Difference of height z-score no 39 -0.3 -2.5 1.7 0.617
yes 19 -0.2 -2.6 2.3
Initial GFR no 39 146.6 50.2 371.2 0.993
yes 19 146.8 56.4 445.5
Final GFR no 39 201.0 92.4 605.0 0.388
yes 19 178.2 90.2 467.5
Difference of GFR no 39 54.4 -228.2 487.7 0.272
yes 19 31.4 -48.1 160.9
(*) Student’s t-test for paired samples.
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194patients is desirable in order to treat complications as soon
as possible to prevent further renal damage.
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